Here are the 5 multimillionaire scientists and executives getting the richest off Moderna's spike to record highs
David L. Ryan/The Boston Globe/Getty Images
Moderna stock leaped to record highs on Monday, minting new fortunes for a small group of executives and scientists.
The biotech company's shares surged as much as 15%, to a record intraday high of $103.20, after announcing the latest trial results for its experimental coronavirus vaccine. The drug was 94.5% effective at preventing COVID-19 in trial patients, Moderna said Monday morning. The company plans to apply for emer...